Romano Sarah 4
4 · KIORA PHARMACEUTICALS INC · Filed Feb 11, 2022
Insider Transaction Report
Form 4
Romano Sarah
Interim CFO
Transactions
- Tax Payment
Common Stock
2022-02-10$0.69/sh−108$75→ 22,746 total
Footnotes (2)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 02/01/2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.70, inclusive. The reporting person hereby undertakes to provide to Kiora Pharmaceuticals, Inc., any security holder of Kiora Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.